We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Cites Sovereign Pharmaceuticals for Multiple Quality Control Problems
FDA Cites Sovereign Pharmaceuticals for Multiple Quality Control Problems
Sovereign Pharmaceuticals, a contract development and manufacturing organization (CDMO) based in Fort Worth, Texas, has received an FDA warning letter citing multiple quality control issues that led to inconsistent tablet weights.